Revenue segments as reported by the company.

Premiums earned, net

Other income

Investment income, net

Direct Contracting revenue

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Net medical claims incurred

Salaries and benefits

General and administrative expenses

Premium deficiency reserve (benefit) expense

Depreciation and amortization

Other expense

Restructuring costs

Impairment of goodwill and other intangible assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Clover Health Investments

Clover Health Investments Corp. provides healthcare insurance services. It uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients. The company was founded on July 17, 2014 and is headquartered in Franklin, TN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Clover Health reports profitable Q1, poised for sustained growth

Clover Health Investments had a strong Q1 performance, expecting full-year profitability and revenue growth. With a focus on operational enhancements, revenue growth, and cost reductions, the company aims to maintain momentum in 2024 amidst industry challenges. Clover's strategic initiatives like share repurchase program and product enhancements position it well for sustained growth and care management excellence.

Clover Health achieves profitability milestone and eyes market expansion

Clover Health's Q2 2024 earnings call reflects a positive trajectory with increased profitability, strong revenue growth, and improved guidance for the full year.
The company's strategic focus on operational efficiency, technology innovation, and market validation positions it well for sustainable growth and market expansion.
While facing challenges in maintaining profitability and implementing technology enhancements, Clover Health has opportunities to capitalize on market interest and drive further growth in the Medicare Advantage sector.

Clover Health reports strong Q3 performance and eyes growth opportunities

Clover Health Investments (CLOV) showcased strong financial performance and strategic investments in growth areas during the Q3 2024 earnings call. The company's focus on membership growth, quality initiatives, and technology enhancements, along with exploring health partnerships, highlights a promising outlook for future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Clover Health Investments Corp. is a physician enablement technology company that provides Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. Clover Health Investments was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Franklin, TN.

ARK Innovation ETF

Bumble

Opendoor

Penn Entertainment

Riot Blockchain

Virgin Galactic

Tesla

Marathon Digital Holdings

When it comes to investing trends, just follow the people who can influence those outcomes. Here are 9 post-pandemic summer saviors to watch.

9 Post-Pandemic Summer Saviors Every Investor Should Keep An Eye On

Despite strong revenue numbers, CLOV stock is facing heavy short interest. But risk-tolerant investors may see it as a buying opportunity.

Clover Health Is Only For the Most Risk-Tolerant Investors

CLOV Stock is building its base for long term top-line growth and to cement its position as the leading Medicare insurance company The post Clover Health Investments Is a Solid Buy Contrary to All of the Bearish Calls appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now It doesn't matter if you have $500 in savings or $5 million.

Clover Health Investments Is a Solid Buy Contrary to All of the Bearish Calls

Investors focused on the negatives with the company's first-quarter results more than the positives.

Why Clover Health Stock Sank Today

The company told investors before its SPAC merger that it expected 200,000 new members through Medicare direct contracting this year. On Monday, the company said it now expects half that—or even less.

Clover Health Expects Slower Medicare Member Growth And Lower Revenue Than Previously Projected

CLOV stock went public as a play on the healthcare sector, but now its own health seems at risk amid some serious allegations. The post After Checking Its Health, Things Do Not Look Good for CLOV Stock appeared first on InvestorPlace.

After Checking Its Health, Things Do Not Look Good for CLOV Stock

Shares of CLOV stock are falling on Monday despite Clover Health reporting solid earnings results for the first quarter of fiscal year 2021. The post CLOV Stock: 5 Things to Know About Trending Reddit Favorite Clover Health Today appeared first on InvestorPlace.

CLOV Stock: 5 Things to Know About Trending Reddit Favorite Clover Health Today

Clover Health Investments, Corp. (CLOV) CEO Vivek Garipalli on Q1 2021 Results - Earnings Call Transcript

Clover Health, a Wall Streets Bets favorite, rose after the health insurer reported a revenue beat in its first-quarter earnings results.  Clover, which sells private health plans for seniors in the Medicare Advantage market, reported revenue of $200.3 million in the quarter, topping the $193 million average estimate from two analysts, Markets Insider data showed. It also reported a net loss of $48.4 million for the quarter, a widening from the $28.2 million loss from the same time last year.

Chamath Palihapitiya-backed Clover Health climbs after earnings amid chatter from Wall Street Bets cheerleaders

The Medicare-focused company delivered strong top-line growth but a deteriorating bottom line.

What to Like (and Dislike) About Clover Health's Q1 Results

Clover Health Investments Corp (NASDAQ:CLOV) shares are trading lower by 1% at $7.40 in Monday's pre-market session after the company reported better-than-expected first-quarter sales results. Clover Health reported quarterly sales of $200.30 million, which beat the analyst consensus estimate of $166.23 million.

Why Clover Health Stock Is Moving Today

Record Revenue of Over $200 million Lives Under Management Nearly Doubles Following The Launch of Direct Contracting

Clover Health Reports First Quarter 2021 Financial Results

Applied Genetic Technologies

Atossa Genetics

Citius Pharmaceuticals

Senseonics Holdings

InvestorPlace is closing out a busy week of trading with a look at the Reddit penny stocks seeing the most chatter on Friday. The post 5 Reddit Penny Stocks Seeing the Most Chatter Friday appeared first on InvestorPlace.

5 Reddit Penny Stocks Seeing the Most Chatter Friday

Clover stock is stuck in a dryer tumble of losses and more Losses. CLOV stock will fall if the company does not produce Q1 numbers on May 17 that imply full year 24% growth.

Clover Stock Is Stuck In a Dryer Tumble of Losses and More Losses

Coinbase

Lordstown Motors

Today's look at earnings reports due the end of this week and the start of next week begins with a company we missed in our preview yesterday that will be reporting results after markets close Thursday.

Earnings Previews: Clover Health, Coinbase, Lordstown Motors

CLOV stock has absorbed a steep discount and when you consider the broader context, it probably deserves it. The post Clover Health Stock Simply Has Too Much Toxic Baggage Right Now appeared first on InvestorPlace.

Clover Health Stock Simply Has Too Much Toxic Baggage Right Now

SAN DIEGO & FRANKLIN, Tenn.--(BUSINESS WIRE)---- $CLOV #ClassAction--Shareholder rights law firm Robbins LLP is investigating Clover Health Investments, Corp. (NASDAQ: CLOV) on behalf of shareholders to determine whether certain Clover officers and directors violated the Securities Exchange Act of 1934 and breached their fiduciary duties to the Company. Clover Health provides medical insurance services. If you suffered a loss due to Clover Health Investment Corp.'s misconduct, click here. Clover Health Investment, Co

Shareholder Alert: Robbins LLP is Investigating Clover Health Investments, Corp. (CLOV) on Behalf of Shareholders

PHILADELPHIA, May 10, 2021 /PRNewswire/ -- Roundtrip, the leading digital healthcare transportation marketplace, announces it is working with Clover Health (Nasdaq: CLOV), an innovative technology company improving health outcomes for America's seniors, to offer non-emergency medical transportation to Clover's Medicare Advantage members. The goal of the collaboration is to combat one of the most significant barriers to care for seniors in America: transportation.

Roundtrip Partners with Clover Health to Provide Medicare Advantage Members with Non-Emergency Transportation Services

CLOV stock cannot return to its early glory unless investors are convinced that its technology platform gives it a solid competitive moat. The post Clover Health Faces Hurdles to Reach New Highs appeared first on InvestorPlace.

Clover Health Faces Hurdles to Reach New Highs

Long-term investors should take a wait-and-see attitude.

Should Investors Be Worried About Clover Health's Class Action Lawsuits?

CLOV stock is being pushed and pulled in multiple directions. Investors won't have an easy time making a judgment right now, so hold off.

Clover Health Is Fraught with Mixed Signals

Clover Heath Investments Corp. (NASDAQ: CLOV) shares are trading lower Wednesday morning. The share price has fallen throughout the past week, the drop is potentially due to Lifshitz Law Firm announcing on May 2 the firm is going to start an investigation of Clover Health.

Where Could Clover Health Go In The Coming Weeks?

The company's Clover Assistant proprietary platform is the most important lever, but may not be significant enough to be considered a wide moat. Clover Health must do more to scale up its CA platform to penetrate its markets further and ramp up its revenue growth aggressively.

Clover Health Is Still Expensive

Clover Health reports first-quarter results on May 17. Given what we know about its 2020 results, is CLOV stock a buy ahead of earnings?

Is Clover Health a Buy Ahead of Earnings?

Bulls got a little too exuberant about the short squeeze potential for CLOV stock. However, there's still a possibility of further trading gains.

News for Clover Health Investments Stock (CLOV)